logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO-IO 2019 – Immunotherapy combination for loco-regionally advanced bladder cancer in the neoadjuvant setting

New study shows improved outcomes in surgery naïve, cisplatin ineligible bladder cancer patients.